You are currently logged into
POZ Directory - My Account or Log Out
POZ POZ
  • Home
  • Basics
    • Basics
    • Introduction
    • HIV Transmission and Risks
    • HIV Testing
    • HIV Prevention
    • Newly Diagnosed
    • Starting HIV Treatment
    • HIV Medications
    • HIV Drug Assistance Programs
    • HIV/HCV Coinfection
    • VIH/SIDA en Español
  • News
    • News
    • Newsfeed
    • Treatment News
    • Features
    • Opinions
    • Conferences
    • Slideshows
    • Videos
    • POZ TV
    • POZ Stories
    • POZ 100
    • By Author
    • RSS Links
  • Hot Topics
    • Hot Topics
    • World AIDS Day
    • POZ Awards
    • POZ at 25
    • POZ 100
    • Advocacy
    • Cure
    • Undetectable (U=U)
    • Prevention
    • PrEP
    • Criminalization
    • Newly Diagnosed
    • Long-Term Survivors
    • Youth
  • Magazine
    • Magazine
    • Current Issue
    • Archives
    • Digital Editions
    • POZ Focus
    • Subscriptions
    • Email Newsletters
  • Blogs
    • Blogs
    • Recent Posts
    • Browse Bloggers
    • RSS Links
  • Community
    • Community
    • POZ Personals
    • POZ Stories
    • POZ 100
    • Community
    • AIDS Is Everyday
    • Forums
    • Polls
    • Surveys
    • Quizzes
    • Ask POZ
    • Services Directory
    • Calendar
    • Jobs
    • Bookstore
  • About Us
    • About Us
    • About Us
    • Masthead
    • Awards
    • Press Releases
    • Advertise
    • Contact Us
  • Facebook
  • Twitter

© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

© 2019 Smart + Strong.
All Rights Reserved.
Terms of use and
Your privacy.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.

Advertisement

Share


Twitter
Facebook
Pinterest
Tumblr
Email

#IDWeek 2012

Tweet
  • Share

Brief Treatment Interruptions for Cure Studies Are Safe, Well-Tolerated

Short treatment interruptions of antiretroviral regimens are both safe and well-tolerated, which is good news for scientists pursuing cures.

Stribild Is as Safe, Effective as Atripla, Even Among Less-Adherent

New research shows Stribild, a.k.a. the Quad, is as effective and safe as Atripla in those who don’t adhere perfectly to their regimens. 

Twice-Yearly Checkups May Be All That’s Needed to Control HIV

People with undetectable viral loads experience same rates of virologic control whether they undergo checkups every three or six months.

Hep C Hospital Admissions Spike Fivefold; Those for HIV Drop by Half

Hospital admission rates for people coinfected with both HIV and hepatitis C slightly more than doubled.

Most Inmates Linked to HIV Care in Jail Drop Out Upon Release

Only 38 percent of those linked to HIV care while in jail maintain steady checkups after release.

High Rates of HIV Med Prescribing Errors Among Hospitalized Patients

Mistakes are common when it comes to prescribing antiretrovirals to people living with HIV who have been hospitalized. 

Advertisement

Stay Logged In?

You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.

You Have Been Logged Out

Click here to log back in.